GC
MBOT icon

Guggenheim Capital’s Microbot Medical MBOT Stock Holding History

Guggenheim Capital’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-776
Closed -$8K – 2509
2018
Q1 		$8K Buy
776
+5
+0.6% +$68 ﹤0.01% 2767
2017
Q4 		$12K Sell
771
-96
-11% -$1.63K ﹤0.01% 2685
2017
Q3 		$15K Buy
+867
New +$15.3K ﹤0.01% 2761
2015
Q4 		– Sell
-17
Closed -$12K – 3041
2015
Q3 		$12K Buy
17
+2
+13% +$1.52K ﹤0.01% 2921
2015
Q2 		$13K Buy
15
+8
+114% +$9.41K ﹤0.01% 3010
2015
Q1 		$11K Hold
7
– – ﹤0.01% 3017
2014
Q4 		$10K Buy
+7
New +$12.7K ﹤0.01% 2991
2014
Q3 		– Sell
-13
Closed -$42K – 3071
2014
Q2 		$42K Sell
13
-1
-7% -$2.31K ﹤0.01% 3099
2014
Q1 		$31K Buy
14
+3
+27% +$7.17K ﹤0.01% 3190
2013
Q4 		$22K Buy
11
+1
+10% +$2.12K ﹤0.01% 3127
2013
Q3 		$28K Hold
10
– – ﹤0.01% 2994
2013
Q2 		$27K Buy
+10
New +$28.2K ﹤0.01% 2962

Other funds holding MBOT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Guggenheim Capital's MBOT Position: Q2 2018 in Review

Guggenheim Capital sold out of Microbot Medical (MBOT) in Q2 2018, closing a stake of 776 shares — an estimated $8K sold.

Guggenheim Capital first reported a position in MBOT in Q2 2013 and held it in 12 quarters. The position peaked at $42K in Q2 2014. 26 funds tracked by Wall St. Rank hold MBOT as of Q2 2018.

  • Guggenheim Capital reported no remaining Microbot Medical position as of Q2 2018 after selling out during the quarter.
  • Guggenheim Capital sold 776 Microbot Medical shares in Q2 2018, an estimated $8K.
  • Guggenheim Capital first reported a position in Microbot Medical in Q2 2013 and held it in 12 quarters.
  • Guggenheim Capital's Microbot Medical position peaked at $42K in Q2 2014.
  • 26 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2018.

Based on Guggenheim Capital's 13F filing for Q2 2018, filed 14 Aug 2018.